GSK’s Nucala gains US use in rare autoimmune disease
IL-5 drug approved in EGPA
X
GSK’s Nucala gains US use in rare autoimmune disease
https://pharmaphorum.com/news/gsks-nucala-gains-us-use-rare-autoimmune-disease/
IL-5 drug approved in EGPA
